Wally Meyer

890 total citations
8 papers, 623 citations indexed

About

Wally Meyer is a scholar working on Oncology, Hematology and Genetics. According to data from OpenAlex, Wally Meyer has authored 8 papers receiving a total of 623 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Oncology, 3 papers in Hematology and 2 papers in Genetics. Recurrent topics in Wally Meyer's work include Hematopoietic Stem Cell Transplantation (3 papers), Neutropenia and Cancer Infections (2 papers) and Virus-based gene therapy research (1 paper). Wally Meyer is often cited by papers focused on Hematopoietic Stem Cell Transplantation (3 papers), Neutropenia and Cancer Infections (2 papers) and Virus-based gene therapy research (1 paper). Wally Meyer collaborates with scholars based in United States. Wally Meyer's co-authors include John Pippen, Svetislava J. Vukelja, Frankie A. Holmes, Hyman B. Muss, Donald Richards, Kristi A. Boehm, Lina Asmar, Joyce O’Shaughnessy, Michael A. Savin and John F. Sandbach and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Clinical Infectious Diseases.

In The Last Decade

Wally Meyer

8 papers receiving 588 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wally Meyer United States 7 395 264 108 86 70 8 623
Cheryl Sickles United States 6 266 0.7× 141 0.5× 102 0.9× 132 1.5× 38 0.5× 7 637
John F. Speer United States 9 211 0.5× 159 0.6× 81 0.8× 50 0.6× 32 0.5× 15 570
Phillip Periman United States 13 293 0.7× 61 0.2× 131 1.2× 180 2.1× 24 0.3× 26 693
Jeffrey Schneider United States 15 592 1.5× 86 0.3× 139 1.3× 160 1.9× 38 0.5× 40 882
Sebastian Belle Germany 17 455 1.2× 153 0.6× 54 0.5× 219 2.5× 59 0.8× 65 852
William P. Peters United States 12 271 0.7× 63 0.2× 97 0.9× 90 1.0× 22 0.3× 15 488
Jacqueline S. Hart United States 12 189 0.5× 88 0.3× 282 2.6× 70 0.8× 42 0.6× 16 610
Jorge A. Spinolo United States 11 436 1.1× 83 0.3× 379 3.5× 70 0.8× 68 1.0× 18 794
Maria Koch Canada 12 263 0.7× 66 0.3× 52 0.5× 123 1.4× 81 1.2× 28 644
H Ørjasæter Norway 13 135 0.3× 97 0.4× 42 0.4× 51 0.6× 33 0.5× 41 510

Countries citing papers authored by Wally Meyer

Since Specialization
Citations

This map shows the geographic impact of Wally Meyer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wally Meyer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wally Meyer more than expected).

Fields of papers citing papers by Wally Meyer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wally Meyer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wally Meyer. The network helps show where Wally Meyer may publish in the future.

Co-authorship network of co-authors of Wally Meyer

This figure shows the co-authorship network connecting the top 25 collaborators of Wally Meyer. A scholar is included among the top collaborators of Wally Meyer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wally Meyer. Wally Meyer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Jones, Stephen E., Frankie A. Holmes, Joyce O’Shaughnessy, et al.. (2009). Docetaxel With Cyclophosphamide Is Associated With an Overall Survival Benefit Compared With Doxorubicin and Cyclophosphamide: 7-Year Follow-Up of US Oncology Research Trial 9735. Journal of Clinical Oncology. 27(8). 1177–1183. 400 indexed citations
2.
Osborne, Cynthia R., Scot Sedlacek, Devchand Paul, et al.. (2009). The addition of hormone therapy to tamoxifen does not prevent hot flashes in women at high risk for developing breast cancer. Breast Cancer Research and Treatment. 116(3). 521–527. 8 indexed citations
3.
Nemunaitis, John, Timothy Fong, Francis Burrows, et al.. (1999). Phase I Trial of Interferon gamma Retroviral Vector Administered Intratumorally with Multiple Courses in Patients with Metastatic Melanoma. Human Gene Therapy. 10(8). 1289–1298. 39 indexed citations
4.
Brawner, D L, Raleigh A. Bowden, Wally Meyer, et al.. (1995). Fungal Liver Infection in Marrow Transplant Recipients: Prevalence at Autopsy, Predisposing Factors, and Clinical Features. Clinical Infectious Diseases. 20(4). 801–811. 54 indexed citations
5.
Benyunes, Mark, Keith M. Sullivan, H. Joachim Deeg, et al.. (1995). Cataracts after bone marrow transplantation: Long-term follow-up of adults treated with fractionated total body irradiation. International Journal of Radiation Oncology*Biology*Physics. 32(3). 661–670. 69 indexed citations
6.
Nemunaitis, John, C Rosenfeld, Wally Meyer, et al.. (1995). Pentoxifylline and Ciprofloxacin in Patients with Myelodysplastic Syndrome. American Journal of Clinical Oncology. 18(3). 189–193. 25 indexed citations
7.
Bearman, SI, P Beatty, Wally Meyer, et al.. (1994). Comparison of morbidity and mortality after marrow transplantation from HLA-genotypically identical siblings and HLA-phenotypically identical unrelated donors.. PubMed. 13(1). 31–5. 25 indexed citations
8.
Nemunaitis, John, FR Appelbaum, K Lilleby, et al.. (1994). Phase I study of recombinant interleukin-1 beta in patients undergoing autologous bone marrow transplant for acute myelogenous leukemia. Blood. 83(12). 3473–3479. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026